Skip to main content
SpringerLink
Log in

Incidence of Nephropathy in IDDM as Related to Mortality. Costs and Benefits of Early Intervention

  • Chapter
The Kidney and Hypertension in Diabetes Mellitus

  • 107 Accesses

Abstract

Development of persistent proteinuria — the clinical manifestation of diabetic nephropathy — is a strong prognostic marker in IDDM-patients. Not only does it precede the development of end stage renal failure, it is also associated with an increased risk of proliferative retinopathy, visual impairment and blindness, and with an increased risk of atherosclerosis leading to peripheral vascular disease and amputations, coronary artery disease, myocardial infarction, Sudden death and cerebrovascular disease and stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S & Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: and epidemiological study. Diabetologia 1983;25:496–501.

    Article  PubMed  CAS  Google Scholar 

  2. Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T. Declining incidence of persistent proteinuria in Type 1 (insulin-dependent) diabetic patients in Denmark. Diabetes 1987;36:205–209.

    Article  PubMed  CAS  Google Scholar 

  3. Krolewski AS, Warram JH, Christlieb ARE, Busick EJ, Kahn CR. The changing natural history of nephropathy in Type 1 diabetes. Am J Med 1985;78:785–794.

    Article  PubMed  CAS  Google Scholar 

  4. Tchobroutsky G. Relation of diabetic control to development of microvascular complications. Diabetologia 1978;15:143–153.

    Article  PubMed  CAS  Google Scholar 

  5. Bojestig M, Amqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994;330:15–18.

    Article  PubMed  CAS  Google Scholar 

  6. Mortensen HB, Hougaard P. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. Diabetes Care 1997;20:714.

    Article  PubMed  CAS  Google Scholar 

  7. Rossing P, Rossing K, Jacobsen P, Parving HH. Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 1995;44:739–743.

    Article  PubMed  CAS  Google Scholar 

  8. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.

    Article  Google Scholar 

  9. Borch-Johnsen K. The prognosis of insulin-dependent diabetes mellitus. Dan Med Bull 1989;36:336–348.

    PubMed  CAS  Google Scholar 

  10. Diabetes Epidemiology Research International (DERI) Mortality Study Group. Major Cross-Country differences in risk of dying for people with IDDM Diabetes Care 1991;14:49–54.

    Google Scholar 

  11. Watson PJ, Blainey JD, Brewer DB, Fitzgerald MG, Malins JM, O’SulIivan DJ, Pinto JA. The natural history of diabetic renal disease. Q J Med 1972;164:437–456.

    Google Scholar 

  12. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in Type 1 (msulm-dependent) diabetes mellitus. Diabetologia 1985;28:590–596.

    Article  PubMed  CAS  Google Scholar 

  13. Parving HH, Hommel E. Prognosis in diabetic nephropathy. BMJ 1989;299:230–233.

    Article  PubMed  CAS  Google Scholar 

  14. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 1996;313:779–784.

    Article  PubMed  CAS  Google Scholar 

  15. Jensen T, Borch-Johnsen K, Deckert T. Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with diabetic nephropathy: Incidence and risk factors. Diabetologia 1987;30:144–148.

    Article  CAS  Google Scholar 

  16. Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardio-vascular mortality in insulin-dependent diabetes mellitus. Br Med J 1987;294:1651–1654.

    Article  CAS  Google Scholar 

  17. Borch-Johnsen K, Kreiner S, Deckert T. Mortality of Type 1 (insulin-dependent) diabetes mellitus in Denmark. Diabetologia 1986;29:767–772.

    Article  PubMed  CAS  Google Scholar 

  18. Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulos A, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus. Lancet 1982; i: 1430–1432.

    Article  Google Scholar 

  19. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89–93.

    Article  PubMed  CAS  Google Scholar 

  20. Mathiesen ER, Oxenboll B, Johansen K, Svendsen PAa, Deckert T. incipient nephropathy in Type 1 (insulin-dependent) diabetes. Diabetologia 1984;26:406–410.

    Article  PubMed  CAS  Google Scholar 

  21. Jensen T. Albuminuria — a marker of renal and generalized vascular disease in insulin-dependent diabetes mellitus. Dan Med Bull 1991;38:134–144.

    PubMed  CAS  Google Scholar 

  22. Feldt-Rasmussen B. Microalbuminuria and clinical nephropathy in Type 1 (insulin-dependent) diabetes mellitus: pathophysiological mechanisms and intervention studies. Dan Med Bull 1989;36:405–415.

    PubMed  CAS  Google Scholar 

  23. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, and Parving H-H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995 ;44:1303–1309.

    CAS  Google Scholar 

  24. Agewall S, Wikstrand J, Ljungman S, Herlitz H, and Fagerberg B. Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? AJH 1995;8:337–342.

    PubMed  CAS  Google Scholar 

  25. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984;310:356–360.

    Article  PubMed  CAS  Google Scholar 

  26. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ. Microalburninuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1984;1:17–19.

    Article  PubMed  CAS  Google Scholar 

  27. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988; ii:530–533.

    Article  Google Scholar 

  28. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Micro-albuminuria as predictor of increased mortality in elderly people. BMJ 1990;300:297–300.

    Article  PubMed  CAS  Google Scholar 

  29. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Microalbuminuria: a novel independent risk factor for ischemic heart disease. Submitted BMJ 1997.

    Google Scholar 

  30. Messent JWC, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty year follow-up study. Kidney Int 1992;41:836–839.

    Article  PubMed  CAS  Google Scholar 

  31. Deckert T, Yokoyama H, Mathiesen ER, Rann B, Jansen T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen JS. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in insulin dependent diabetes. BMJ 1996;312:871–874.

    Article  PubMed  CAS  Google Scholar 

  32. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988;297:1092–1095.

    Article  PubMed  CAS  Google Scholar 

  33. Mathiesen ER, Hommel E, Giese J, Parving H-H. Efficacy of Captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. BMJ 1991;303:81–87.

    Article  PubMed  CAS  Google Scholar 

  34. Melbourne Diabetic nephropathy study group. Comparison between Perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ 1991;302:210–216.

    Article  Google Scholar 

  35. Viberti GC, Mogensen CE, Groop L, Pauls JF for the European Microalbuminuria Captopril Study Group. Effect of Captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994;271:275–279.

    Article  Google Scholar 

  36. Sawicki PT, Mühlhaser I, Bender R, Pethke W, Heinemarm L, Berger M. Effects of smoking on blood pressure and proteinuria in patients with diabetic nephropathy. J Mem Med 1996;239:345–352.

    CAS  Google Scholar 

  37. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal disease: a meta-analysis. Arm Intern Med 1996;124:627–632.

    Article  CAS  Google Scholar 

  38. Eggers PW. Health Care Policies/economics of the geriatric renal population. Am J Kidney Dis 1990;16:384–391.

    PubMed  CAS  Google Scholar 

  39. Siegel JE, Krolewski AS, Warram JH, Weinstein MC. Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus. J AM Soc Nephrol 1992;3:3111–3119.

    Google Scholar 

  40. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE. Is screening and intervention for Microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ 1993;306:1722–1725.

    Article  PubMed  CAS  Google Scholar 

  41. Ramlau-Hansen H, Bang Jespersen NC, Andersen PK, Borch-Johnsen K, Deckert T. Life insurance for insulin-dependent diabetics. Scand Actuarial J 1987;19–36.

    Google Scholar 

  42. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991;34:164–170.

    Article  PubMed  CAS  Google Scholar 

  43. Parving H-H, Andersen ARE, Smidt UM, Svendsen PAA Early aggressive antihypertensive treatment reduces the rate of decline in kidney function in diabetic nephropathy. Lancet 1983; i:1175–1179.

    Article  Google Scholar 

  44. Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T. Improved survival in patients with diabetic nephropathy. Diabetologia 1989;32:884–886.

    Article  PubMed  CAS  Google Scholar 

  45. Kiberd BA, Jindal KK. Screening to prevent renal failure in insulin dependent diabetic patients: an economical evaluation: BMJ 1995;311:595–599.

    Google Scholar 

  46. Microalbuminuria Collaborative Study Group, UK. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. BMJ 1993;306:1235–1239.

    Article  Google Scholar 

  47. Hansen KW, Christensen CK, Andersen PH, Mau Pedersen M, Christiansen JS, Mogensen CE. Ambulatory blood pressure in microalbuminuria type 1 diabetic patients. Kidney Int 1992;41:847–854.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Steno Diabetes Centre, Gentofte, Denmark

    Knut Borch-Johnsen

Authors
  1. Knut Borch-Johnsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Department M (Diabetes & Endocrinology), Aarhus Kommunehospital, Aarhus University Hospital, Aarhus C, Denmark

    Carl Erik Mogensen

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Borch-Johnsen, K. (1998). Incidence of Nephropathy in IDDM as Related to Mortality. Costs and Benefits of Early Intervention. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6752-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6752-0_17

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6754-4

  • Online ISBN: 978-1-4757-6752-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation